Tag Archives: The Stem Cell Blog

FDA cracks down on stem-cell clinics selling unapproved treatments … – 89.3 KPCC

Continue reading

2017-08-29 NEWS

89.3 KPCC

FDA cracks down on stem-cell clinics selling unapproved treatments …
89.3 KPCC
Adult stem cells can be extracted from human fat. Patrick T. Fallon/The Washington Post/Getty Images. 169120 full. Share. Share via Email email; Share on …
FDA Cracking Down On Unapproved Stem Cell TreatmentsThe Onion (satire)
FDA announces action against two stem cell clinics: Is that a ‘crackdown’?HealthNewsReview.org
FDA Stem Cell Clinics Crackdown: Agency Targets Unproven TreatmentNewsmax
Pain News Network –FDA.gov
all 28 news articles »
Continue reading

2017-08-29 NEWS

Gene Therapy for the Eyes: Ophthalmology Times
MedPage Today
One expert explores how to manage suprachorodial hemorrhage effectively using a minimally invasive surgical technique. According to Paul Sieving, director of the National Eye Institute, “There is a compelling need to explore gene therapy in the eye.”.

Continue reading

2017-08-29 NEWS

Cancer Gene Therapy Market: Latest Trends and Insights by 2021
Medgadget (blog)
“Global Cancer Gene Therapy Sales Market Report 2017” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The broad field of gene therapy promises a number of innovative treatments that are likely to become important in …

and more »

Continue reading

2017-08-29 NEWS

San Francisco Chronicle

‘Game-changer’ cancer treatment is focus of Gilead’s $12 billion cell therapy deal
San Francisco Chronicle
The deal with Santa Monica’s Kite is expected to close later this year and will intensify competition among major drug companies to introduce a cutting-edge cancer treatment known as CAR T cell therapy. The therapy extracts a patient’s own cells from
New drug price questions loom after Gilead’s cancer purchaseFairfield Daily Republic
Gilead’s $11.9 billion purchase of a groundbreaking cancer therapy could drag it into a new debate on pricesWashington Post
Analysts Mixed On Gilead-Kite, But One Key Rival Stands To BenefitInvestor’s Business Daily
Insider Financial –ClickLancashire
all 41 news articles »
Continue reading

2017-08-29 NEWS

San Francisco Chronicle

‘Game-changer’ cancer treatment is focus of Gilead’s $12 billion cell therapy deal
San Francisco Chronicle
The deal with Santa Monica’s Kite is expected to close later this year and will intensify competition among major drug companies to introduce a cutting-edge cancer treatment known as CAR T cell therapy. The therapy extracts a patient’s own cells from
New drug price questions loom after Gilead’s cancer purchaseFairfield Daily Republic
Gilead’s $11.9 billion purchase of a groundbreaking cancer therapy could drag it into a new debate on pricesWashington Post
Here’s How Our Readers Just Scored Big With Immunomedics Inc (NASDAQ:IMMU)Insider Financial

all 41 news articles »